Global Transdermal Gel Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 01-Nov-2022
No. of pages: 118
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Transdermal Gel manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Transdermal Gel market. Further, it explains the major drivers and regional dynamics of the global Transdermal Gel market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- 3M

- Boehringer Ingelheim International

- Mylan

- Norvartis

- GSK

- Novel Pharmaceutical

- LTS Lohmann

- Johson & Johson

- Bayer

- Actavis

- Corium

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Transdermal Gel Segment by Type

- Ionophoresis

- Electroporation

- Sonophoresis

Transdermal Gel Segment by Application

- Hospital

- Clinic

- Other

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Transdermal Gel market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Transdermal Gel, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Transdermal Gel, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Transdermal Gel, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transdermal Gel sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Transdermal Gel market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Transdermal Gel sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including 3M, Boehringer Ingelheim International, Mylan, Norvartis, GSK, Novel Pharmaceutical, LTS Lohmann, Johson & Johson and Bayer, etc.

Global Transdermal Gel Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Transdermal Gel Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Ionophoresis
1.2.3 Electroporation
1.2.4 Sonophoresis
1.3 Market Segment by Application
1.3.1 Global Transdermal Gel Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Transdermal Gel Market Size (2017-2028)
2.1.1 Global Transdermal Gel Revenue (2017-2028)
2.1.2 Global Transdermal Gel Sales (2017-2028)
2.2 Global Transdermal Gel Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Transdermal Gel Sales by Regions (2017-2022)
2.2.2 Global Transdermal Gel Revenue by Regions (2017-2022)
2.3 Global Transdermal Gel Market Size Forecast by Region
2.3.1 Global Transdermal Gel Sales Forecast by Region (2023-2028)
2.3.2 Global Transdermal Gel Revenue Forecast by Region (2023-2028)
2.4 Global Top Transdermal Gel Regions (Countries) Ranking by Market Size
2.5 Transdermal Gel Market Dynamics
2.5.1 Transdermal Gel Market Trends
2.5.2 Transdermal Gel Market Drivers
2.5.3 Transdermal Gel Market Challenges
2.5.4 Transdermal Gel Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Transdermal Gel Manufacturers by Sales (2017-2022)
3.1.1 Global Transdermal Gel Sales by Manufacturers (2017-2022)
3.1.2 Global Transdermal Gel Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Transdermal Gel Sales in 2021
3.2 Global Top Manufacturers Transdermal Gel by Revenue
3.2.1 Global Transdermal Gel Revenue by Manufacturers (2017-2022)
3.2.2 Top Transdermal Gel Manufacturers Covered: Ranking by Revenue
3.2.3 Global Transdermal Gel Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Transdermal Gel Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Gel as of 2021)
3.4 Global Transdermal Gel Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Transdermal Gel Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Transdermal Gel Market
3.7 Key Manufacturers Transdermal Gel Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Transdermal Gel Market Size by Type
4.1 Global Transdermal Gel Historic Market Review by Type (2017-2022)
4.1.1 Global Transdermal Gel Sales Market Share by Type (2017-2022)
4.1.2 Global Transdermal Gel Revenue Market Share by Type (2017-2022)
4.1.3 Transdermal Gel Price by Type (2017-2022)
4.2 Global Transdermal Gel Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Transdermal Gel Sales Forecast by Type (2023-2028)
4.2.2 Global Transdermal Gel Revenue Forecast by Type (2023-2028)
4.2.3 Transdermal Gel Price Forecast by Type (2023-2028)
5 Global Transdermal Gel Market Size by Application
5.1 Global Transdermal Gel Historic Market Review by Application (2017-2022)
5.1.1 Global Transdermal Gel Sales Market Share by Application (2017-2022)
5.1.2 Global Transdermal Gel Revenue Market Share by Application (2017-2022)
5.1.3 Transdermal Gel Price by Application (2017-2022)
5.2 Global Transdermal Gel Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Transdermal Gel Sales Forecast by Application (2023-2028)
5.2.2 Global Transdermal Gel Revenue Forecast by Application (2023-2028)
5.2.3 Transdermal Gel Price Forecast by Application (2023-2028)
6 North America
6.1 North America Transdermal Gel Sales Breakdown by Company
6.1.1 North America Transdermal Gel Sales by Company (2017-2022)
6.1.2 North America Transdermal Gel Revenue by Company (2017-2022)
6.2 North America Transdermal Gel Market Size by Type
6.2.1 North America Transdermal Gel Sales by Type (2017-2028)
6.2.2 North America Transdermal Gel Revenue by Type (2017-2028)
6.3 North America Transdermal Gel Market Size by Application
6.3.1 North America Transdermal Gel Sales by Application (2017-2028)
6.3.2 North America Transdermal Gel Revenue by Application (2017-2028)
6.4 North America Transdermal Gel Market Size by Country
6.4.1 North America Transdermal Gel Sales by Country (2017-2028)
6.4.2 North America Transdermal Gel Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Transdermal Gel Sales Breakdown by Company
7.1.1 Europe Transdermal Gel Sales by Company (2017-2022)
7.1.2 Europe Transdermal Gel Revenue by Company (2017-2022)
7.2 Europe Transdermal Gel Market Size by Type
7.2.1 Europe Transdermal Gel Sales by Type (2017-2028)
7.2.2 Europe Transdermal Gel Revenue by Type (2017-2028)
7.3 Europe Transdermal Gel Market Size by Application
7.3.1 Europe Transdermal Gel Sales by Application (2017-2028)
7.3.2 Europe Transdermal Gel Revenue by Application (2017-2028)
7.4 Europe Transdermal Gel Market Size by Country
7.4.1 Europe Transdermal Gel Sales by Country (2017-2028)
7.4.2 Europe Transdermal Gel Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Transdermal Gel Sales Breakdown by Company
8.1.1 Asia Pacific Transdermal Gel Sales by Company (2017-2022)
8.1.2 Asia Pacific Transdermal Gel Revenue by Company (2017-2022)
8.2 Asia Pacific Transdermal Gel Market Size by Type
8.2.1 Asia Pacific Transdermal Gel Sales by Type (2017-2028)
8.2.2 Asia Pacific Transdermal Gel Revenue by Type (2017-2028)
8.3 Asia Pacific Transdermal Gel Market Size by Application
8.3.1 Asia Pacific Transdermal Gel Sales by Application (2017-2028)
8.3.2 Asia Pacific Transdermal Gel Revenue by Application (2017-2028)
8.4 Asia Pacific Transdermal Gel Market Size by Region
8.4.1 Asia Pacific Transdermal Gel Sales by Region
8.4.2 Asia Pacific Transdermal Gel Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Transdermal Gel Sales Breakdown by Company
9.1.1 Latin America Transdermal Gel Sales by Company (2017-2022)
9.1.2 Latin America Transdermal Gel Revenue by Company (2017-2022)
9.2 Latin America Transdermal Gel Market Size by Type
9.2.1 Latin America Transdermal Gel Sales by Type (2017-2028)
9.2.2 Latin America Transdermal Gel Revenue by Type (2017-2028)
9.3 Latin America Transdermal Gel Market Size by Application
9.3.1 Latin America Transdermal Gel Sales by Application (2017-2028)
9.3.2 Latin America Transdermal Gel Revenue by Application (2017-2028)
9.4 Latin America Transdermal Gel Market Size by Country
9.4.1 Latin America Transdermal Gel Sales by Country (2017-2028)
9.4.2 Latin America Transdermal Gel Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Transdermal Gel Sales Breakdown by Company
10.1.1 Middle East and Africa Transdermal Gel Sales by Company (2017-2022)
10.1.2 Middle East and Africa Transdermal Gel Revenue by Company (2017-2022)
10.2 Middle East and Africa Transdermal Gel Market Size by Type
10.2.1 Middle East and Africa Transdermal Gel Sales by Type (2017-2028)
10.2.2 Middle East and Africa Transdermal Gel Revenue by Type (2017-2028)
10.3 Middle East and Africa Transdermal Gel Market Size by Application
10.3.1 Middle East and Africa Transdermal Gel Sales by Application (2017-2028)
10.3.2 Middle East and Africa Transdermal Gel Revenue by Application (2017-2028)
10.4 Middle East and Africa Transdermal Gel Market Size by Country
10.4.1 Middle East and Africa Transdermal Gel Sales by Country (2017-2028)
10.4.2 Middle East and Africa Transdermal Gel Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 3M
11.1.1 3M Corporation Information
11.1.2 3M Overview
11.1.3 3M Transdermal Gel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 3M Transdermal Gel Products and Services
11.1.5 3M Transdermal Gel SWOT Analysis
11.1.6 3M Recent Developments
11.2 Boehringer Ingelheim International
11.2.1 Boehringer Ingelheim International Corporation Information
11.2.2 Boehringer Ingelheim International Overview
11.2.3 Boehringer Ingelheim International Transdermal Gel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Boehringer Ingelheim International Transdermal Gel Products and Services
11.2.5 Boehringer Ingelheim International Transdermal Gel SWOT Analysis
11.2.6 Boehringer Ingelheim International Recent Developments
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Overview
11.3.3 Mylan Transdermal Gel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Mylan Transdermal Gel Products and Services
11.3.5 Mylan Transdermal Gel SWOT Analysis
11.3.6 Mylan Recent Developments
11.4 Norvartis
11.4.1 Norvartis Corporation Information
11.4.2 Norvartis Overview
11.4.3 Norvartis Transdermal Gel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Norvartis Transdermal Gel Products and Services
11.4.5 Norvartis Transdermal Gel SWOT Analysis
11.4.6 Norvartis Recent Developments
11.5 GSK
11.5.1 GSK Corporation Information
11.5.2 GSK Overview
11.5.3 GSK Transdermal Gel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 GSK Transdermal Gel Products and Services
11.5.5 GSK Transdermal Gel SWOT Analysis
11.5.6 GSK Recent Developments
11.6 Novel Pharmaceutical
11.6.1 Novel Pharmaceutical Corporation Information
11.6.2 Novel Pharmaceutical Overview
11.6.3 Novel Pharmaceutical Transdermal Gel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Novel Pharmaceutical Transdermal Gel Products and Services
11.6.5 Novel Pharmaceutical Transdermal Gel SWOT Analysis
11.6.6 Novel Pharmaceutical Recent Developments
11.7 LTS Lohmann
11.7.1 LTS Lohmann Corporation Information
11.7.2 LTS Lohmann Overview
11.7.3 LTS Lohmann Transdermal Gel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 LTS Lohmann Transdermal Gel Products and Services
11.7.5 LTS Lohmann Transdermal Gel SWOT Analysis
11.7.6 LTS Lohmann Recent Developments
11.8 Johson & Johson
11.8.1 Johson & Johson Corporation Information
11.8.2 Johson & Johson Overview
11.8.3 Johson & Johson Transdermal Gel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Johson & Johson Transdermal Gel Products and Services
11.8.5 Johson & Johson Transdermal Gel SWOT Analysis
11.8.6 Johson & Johson Recent Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Overview
11.9.3 Bayer Transdermal Gel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Bayer Transdermal Gel Products and Services
11.9.5 Bayer Transdermal Gel SWOT Analysis
11.9.6 Bayer Recent Developments
11.10 Actavis
11.10.1 Actavis Corporation Information
11.10.2 Actavis Overview
11.10.3 Actavis Transdermal Gel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Actavis Transdermal Gel Products and Services
11.10.5 Actavis Transdermal Gel SWOT Analysis
11.10.6 Actavis Recent Developments
11.11 Corium
11.11.1 Corium Corporation Information
11.11.2 Corium Overview
11.11.3 Corium Transdermal Gel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Corium Transdermal Gel Products and Services
11.11.5 Corium Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Transdermal Gel Value Chain Analysis
12.2 Transdermal Gel Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Transdermal Gel Production Mode & Process
12.4 Transdermal Gel Sales and Marketing
12.4.1 Transdermal Gel Sales Channels
12.4.2 Transdermal Gel Distributors
12.5 Transdermal Gel Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Transdermal Gel Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Ionophoresis
Table 3. Major Manufacturers of Electroporation
Table 4. Major Manufacturers of Sonophoresis
Table 5. Global Transdermal Gel Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Transdermal Gel Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Transdermal Gel Sales by Region (2017-2022) & (K Doses)
Table 8. Global Transdermal Gel Sales Market Share by Region (2017-2022)
Table 9. Global Transdermal Gel Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Transdermal Gel Revenue Market Share by Region (2017-2022)
Table 11. Global Transdermal Gel Sales Forecast by Region (2023-2028) & (K Doses)
Table 12. Global Transdermal Gel Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Transdermal Gel Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Transdermal Gel Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Transdermal Gel Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Transdermal Gel Market Trends
Table 17. Transdermal Gel Market Drivers
Table 18. Transdermal Gel Market Challenges
Table 19. Transdermal Gel Market Restraints
Table 20. Global Transdermal Gel Sales by Manufacturers (2017-2022) & (K Doses)
Table 21. Global Transdermal Gel Sales Share by Manufacturers (2017-2022)
Table 22. Global Transdermal Gel Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Transdermal Gel Manufacturers by Revenue (US$ Million) in 2021
Table 24. Transdermal Gel Revenue Share by Manufacturers (2017-2022)
Table 25. Global Transdermal Gel Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Gel as of 2021)
Table 27. Key Manufacturers Transdermal Gel Average Selling Price (ASP) & (2017-2022) & (USD/Dose)
Table 28. Key Manufacturers Transdermal Gel Plants/Factories Distribution
Table 29. Key Manufacturers Transdermal Gel Area Served
Table 30. Date of Key Manufacturers Enter into Transdermal Gel Market
Table 31. Key Manufacturers Transdermal Gel Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Transdermal Gel Sales (K Doses) by Type (2017-2022)
Table 34. Global Transdermal Gel Sales Share by Type (2017-2022)
Table 35. Global Transdermal Gel Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Transdermal Gel Price (K Doses) by Type (2017-2022)
Table 37. Global Transdermal Gel Sales (K Doses) by Type (2023-2028)
Table 38. Global Transdermal Gel Sales Share by Type (2023-2028)
Table 39. Global Transdermal Gel Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Transdermal Gel Revenue Share by Type (2023-2028)
Table 41. Global Transdermal Gel Price (K Doses) by Type (2023-2028)
Table 42. Global Transdermal Gel Sales (K Doses) by Application (2017-2022)
Table 43. Global Transdermal Gel Sales Share by Application (2017-2022)
Table 44. Global Transdermal Gel Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Transdermal Gel Price (K Doses) by Application (2017-2022)
Table 46. Global Transdermal Gel Sales (K Doses) by Application (2023-2028)
Table 47. Global Transdermal Gel Sales Share by Application (2023-2028)
Table 48. Global Transdermal Gel Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Transdermal Gel Revenue Share by Application (2023-2028)
Table 50. Global Transdermal Gel Price (K Doses) by Application (2023-2028)
Table 51. North America Transdermal Gel Sales by Company (2017-2022) & (K Doses)
Table 52. North America Transdermal Gel Sales Market Share by Company (2017-2022)
Table 53. North America Transdermal Gel Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Transdermal Gel Revenue Market Share by Company (2017-2022)
Table 55. North America Transdermal Gel Sales by Type (2017-2022) & (K Doses)
Table 56. North America Transdermal Gel Sales by Type (2023-2028) & (K Doses)
Table 57. North America Transdermal Gel Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Transdermal Gel Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Transdermal Gel Sales by Application (2017-2022) & (K Doses)
Table 60. North America Transdermal Gel Sales by Application (2023-2028) & (K Doses)
Table 61. North America Transdermal Gel Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Transdermal Gel Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Transdermal Gel Sales by Country (2017-2022) & (K Doses)
Table 64. North America Transdermal Gel Sales by Country (2023-2028) & (K Doses)
Table 65. North America Transdermal Gel Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Transdermal Gel Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Transdermal Gel Sales by Company (2017-2022) & (K Doses)
Table 68. Europe Transdermal Gel Sales Market Share by Company (2017-2022)
Table 69. Europe Transdermal Gel Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Transdermal Gel Revenue Market Share by Company (2017-2022)
Table 71. Europe Transdermal Gel Sales by Type (2017-2022) & (K Doses)
Table 72. Europe Transdermal Gel Sales by Type (2023-2028) & (K Doses)
Table 73. Europe Transdermal Gel Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Transdermal Gel Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Transdermal Gel Sales by Application (2017-2022) & (K Doses)
Table 76. Europe Transdermal Gel Sales by Application (2023-2028) & (K Doses)
Table 77. Europe Transdermal Gel Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Transdermal Gel Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Transdermal Gel Sales by Country (2017-2022) & (K Doses)
Table 80. Europe Transdermal Gel Sales by Country (2023-2028) & (K Doses)
Table 81. Europe Transdermal Gel Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Transdermal Gel Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Transdermal Gel Sales by Company (2017-2022) & (K Doses)
Table 84. Asia Pacific Transdermal Gel Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Transdermal Gel Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Transdermal Gel Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Transdermal Gel Sales by Type (2017-2022) & (K Doses)
Table 88. Asia Pacific Transdermal Gel Sales by Type (2023-2028) & (K Doses)
Table 89. Asia Pacific Transdermal Gel Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Transdermal Gel Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Transdermal Gel Sales by Application (2017-2022) & (K Doses)
Table 92. Asia Pacific Transdermal Gel Sales by Application (2023-2028) & (K Doses)
Table 93. Asia Pacific Transdermal Gel Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Transdermal Gel Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Transdermal Gel Sales by Region (2017-2022) & (K Doses)
Table 96. Asia Pacific Transdermal Gel Sales by Region (2023-2028) & (K Doses)
Table 97. Asia Pacific Transdermal Gel Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Transdermal Gel Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Transdermal Gel Sales by Company (2017-2022) & (K Doses)
Table 100. Latin America Transdermal Gel Sales Market Share by Company (2017-2022)
Table 101. Latin America Transdermal Gel Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Transdermal Gel Revenue Market Share by Company (2017-2022)
Table 103. Latin America Transdermal Gel Sales by Type (2017-2022) & (K Doses)
Table 104. Latin America Transdermal Gel Sales by Type (2023-2028) & (K Doses)
Table 105. Latin America Transdermal Gel Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Transdermal Gel Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Transdermal Gel Sales by Application (2017-2022) & (K Doses)
Table 108. Latin America Transdermal Gel Sales by Application (2023-2028) & (K Doses)
Table 109. Latin America Transdermal Gel Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Transdermal Gel Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Transdermal Gel Sales by Country (2017-2022) & (K Doses)
Table 112. Latin America Transdermal Gel Sales by Country (2023-2028) & (K Doses)
Table 113. Latin America Transdermal Gel Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Transdermal Gel Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Transdermal Gel Sales by Company (2017-2022) & (K Doses)
Table 116. Middle East and Africa Transdermal Gel Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Transdermal Gel Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Transdermal Gel Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Transdermal Gel Sales by Type (2017-2022) & (K Doses)
Table 120. Middle East and Africa Transdermal Gel Sales by Type (2023-2028) & (K Doses)
Table 121. Middle East and Africa Transdermal Gel Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Transdermal Gel Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Transdermal Gel Sales by Application (2017-2022) & (K Doses)
Table 124. Middle East and Africa Transdermal Gel Sales by Application (2023-2028) & (K Doses)
Table 125. Middle East and Africa Transdermal Gel Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Transdermal Gel Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Transdermal Gel Sales by Country (2017-2022) & (K Doses)
Table 128. Middle East and Africa Transdermal Gel Sales by Country (2023-2028) & (K Doses)
Table 129. Middle East and Africa Transdermal Gel Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Transdermal Gel Revenue by Country (2023-2028) & (US$ Million)
Table 131. 3M Corporation Information
Table 132. 3M Description and Overview
Table 133. 3M Transdermal Gel Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 134. 3M Transdermal Gel Product and Services
Table 135. 3M Transdermal Gel SWOT Analysis
Table 136. 3M Recent Developments
Table 137. Boehringer Ingelheim International Corporation Information
Table 138. Boehringer Ingelheim International Description and Overview
Table 139. Boehringer Ingelheim International Transdermal Gel Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 140. Boehringer Ingelheim International Transdermal Gel Product and Services
Table 141. Boehringer Ingelheim International Transdermal Gel SWOT Analysis
Table 142. Boehringer Ingelheim International Recent Developments
Table 143. Mylan Corporation Information
Table 144. Mylan Description and Overview
Table 145. Mylan Transdermal Gel Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 146. Mylan Transdermal Gel Product and Services
Table 147. Mylan Transdermal Gel SWOT Analysis
Table 148. Mylan Recent Developments
Table 149. Norvartis Corporation Information
Table 150. Norvartis Description and Overview
Table 151. Norvartis Transdermal Gel Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 152. Norvartis Transdermal Gel Product and Services
Table 153. Norvartis Transdermal Gel SWOT Analysis
Table 154. Norvartis Recent Developments
Table 155. GSK Corporation Information
Table 156. GSK Description and Overview
Table 157. GSK Transdermal Gel Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 158. GSK Transdermal Gel Product and Services
Table 159. GSK Transdermal Gel SWOT Analysis
Table 160. GSK Recent Developments
Table 161. Novel Pharmaceutical Corporation Information
Table 162. Novel Pharmaceutical Description and Overview
Table 163. Novel Pharmaceutical Transdermal Gel Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 164. Novel Pharmaceutical Transdermal Gel Product and Services
Table 165. Novel Pharmaceutical Transdermal Gel SWOT Analysis
Table 166. Novel Pharmaceutical Recent Developments
Table 167. LTS Lohmann Corporation Information
Table 168. LTS Lohmann Description and Overview
Table 169. LTS Lohmann Transdermal Gel Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 170. LTS Lohmann Transdermal Gel Product and Services
Table 171. LTS Lohmann Transdermal Gel SWOT Analysis
Table 172. LTS Lohmann Recent Developments
Table 173. Johson & Johson Corporation Information
Table 174. Johson & Johson Description and Overview
Table 175. Johson & Johson Transdermal Gel Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 176. Johson & Johson Transdermal Gel Product and Services
Table 177. Johson & Johson Transdermal Gel SWOT Analysis
Table 178. Johson & Johson Recent Developments
Table 179. Bayer Corporation Information
Table 180. Bayer Description and Overview
Table 181. Bayer Transdermal Gel Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 182. Bayer Transdermal Gel Product and Services
Table 183. Bayer Transdermal Gel SWOT Analysis
Table 184. Bayer Recent Developments
Table 185. Actavis Corporation Information
Table 186. Actavis Description and Overview
Table 187. Actavis Transdermal Gel Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 188. Actavis Transdermal Gel Product and Services
Table 189. Actavis Transdermal Gel SWOT Analysis
Table 190. Actavis Recent Developments
Table 191. Corium Corporation Information
Table 192. Corium Description and Overview
Table 193. Corium Transdermal Gel Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 194. Corium Transdermal Gel Product and Services
Table 195. Corium Recent Developments
Table 196. Key Raw Materials Lists
Table 197. Raw Materials Key Suppliers Lists
Table 198. Transdermal Gel Distributors List
Table 199. Transdermal Gel Customers List
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Gel Product Picture
Figure 2. Global Transdermal Gel Sales Market Share by Type in 2021 & 2028
Figure 3. Ionophoresis Product Picture
Figure 4. Electroporation Product Picture
Figure 5. Sonophoresis Product Picture
Figure 6. Global Transdermal Gel Sales Market Share by Application in 2021 & 2028
Figure 7. Hospital Use Case
Figure 8. Clinic Use Case
Figure 9. Other Use Case
Figure 10. Transdermal Gel Report Years Considered
Figure 11. Global Transdermal Gel Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Transdermal Gel Market Size 2017-2028 (US$ Million)
Figure 13. Global Transdermal Gel Sales (2017-2022) & (K Doses)
Figure 14. Global Transdermal Gel Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Transdermal Gel Sales Market Share by Region (2017-2022)
Figure 16. Global Transdermal Gel Sales Market Share by Region in 2021
Figure 17. Global Transdermal Gel Revenue Market Share by Region in 2017 VS 2021
Figure 18. Global Transdermal Gel Sales Share by Manufacturers in 2021
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Transdermal Gel Sales in 2021
Figure 20. Transdermal Gel Revenue Share by Manufacturers in 2021
Figure 21. Transdermal Gel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Transdermal Gel Revenue Share by Type (2017-2022)
Figure 23. Global Transdermal Gel Revenue Growth Rate by Type in 2017 & 2021
Figure 24. Global Transdermal Gel Revenue Share by Application (2017-2022)
Figure 25. Global Transdermal Gel Revenue Growth Rate by Application in 2017 & 2021
Figure 26. North America Transdermal Gel Sales Market Share by Type (2017-2028)
Figure 27. North America Transdermal Gel Revenue Market Share by Type (2017-2028)
Figure 28. North America Transdermal Gel Sales Market Share by Application (2017-2028)
Figure 29. North America Transdermal Gel Revenue Market Share by Application (2017-2028)
Figure 30. North America Transdermal Gel Sales Share by Country (2017-2028)
Figure 31. North America Transdermal Gel Revenue Share by Country (2017-2028)
Figure 32. U.S. Transdermal Gel Revenue (2017-2028) & (US$ Million)
Figure 33. Canada Transdermal Gel Revenue (2017-2028) & (US$ Million)
Figure 34. Europe Transdermal Gel Sales Market Share by Type (2017-2028)
Figure 35. Europe Transdermal Gel Revenue Market Share by Type (2017-2028)
Figure 36. Europe Transdermal Gel Sales Market Share by Application (2017-2028)
F
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs